Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 8/20 | 0.59 |
| ▸ | MEN1 | O00255 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | S100A4 | P26447 | 4/20 | 0.59 |
| ▸ | NPC1 | O15118 | 4/20 | 0.59 |
| ▸ | RAB9A | P51151 | 4/20 | 0.59 |
| ▸ | APAF1 | O14727 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | HTT | P42858 | 3/20 | 0.59 |
| ▸ | GALK1 | P51570 | 3/20 | 0.59 |
| ▸ | BLM | P54132 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | TDP2 | O95551 | 2/20 | 0.59 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | PLCG1 | P19174 | 2/20 | 0.59 |
| ▸ | PPARG | P37231 | 2/20 | 0.59 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2198881 | 0.95 | PTPRC (0.65) | PTPRCMEN1KMT2AS100A4NPC1 | |
| SCHEMBL652915 | 0.91 | MEN1 (0.60) | PTPRCMEN1KMT2AS100A4NPC1 | |
| SCHEMBL29634247 | 0.91 | MEN1 (0.60) | PTPRCMEN1KMT2AS100A4NPC1 | |
| SCHEMBL347152 | 0.91 | MEN1 (0.60) | PTPRCMEN1KMT2AS100A4NPC1 | |
| SCHEMBL29440306 | 0.91 | MEN1 (0.60) | PTPRCMEN1KMT2AS100A4NPC1 | |
| SCHEMBL19230417 | 0.88 | ALDH1A1 (0.52) | PTPRCMEN1KMT2AS100A4NPC1 | |
| SCHEMBL10057987 | 0.85 | MEN1 (0.50) | PTPRCMEN1KMT2AS100A4NPC1 | |
| SCHEMBL236156 | 0.85 | MEN1 (0.67) | PTPRCMEN1KMT2AS100A4NPC1 | |
| SCHEMBL2516264 | 0.85 | MEN1 (0.50) | PTPRCMEN1KMT2AS100A4NPC1 | |
| SCHEMBL54876 | 0.85 | MEN1 (0.50) | PTPRCMEN1KMT2AS100A4NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0940144-A1 | BIOACTIVE POLYMER PRODUCT | EBARA CORPORATION (JP) | 1999-09-08 | — | — | EP | claimed |
| EP-3383405-B1 | ANTIBIOTIC FIIRV 104/18 COMPLEX AND THE ISOLATED INDIVIDUAL FACTORS THEREOF | FONDAZIONE ST INSUBRICO DI RICERCA PER LA VITA (IT) | 2024-06-12 | — | — | EP | disclosed |
| US-20190002942-A1 | ANTIBIOTIC FIIRV 104/18 COMPLEX AND THE ISOLATED INDIVIDUAL FACTORS THEREOF | FONDAZIONE ISTITUTO INSUBRICO DI RICERCA PER LA VITA (IT) | 2019-01-03 | — | — | US | disclosed |
| EP-3383405-A1 | ANTIBIOTIC FIIRV 104/18 COMPLEX AND THE ISOLATED INDIVIDUAL FACTORS THEREOF | Fondazione Istituto Insubrico di Ricerca per la Vita (IT) | 2018-10-10 | — | — | EP | disclosed |
| WO-2017093114-A1 | ANTIBIOTIC FIIRV 104/18 COMPLEX AND THE ISOLATED INDIVIDUAL FACTORS THEREOF | FONDAZIONE ISTITUTO INSUBRICO DI RICERCA PER LA VITA (IT) | 2017-06-08 | — | — | WO | disclosed |
| CN-101048422-B | Benzonaphthaceneglycoside derivative and use thereof | FUJIFILM CORP | 2010-11-17 | — | — | CN | disclosed |
| EP-1810976-A4 | BENZONAPHTHACENEGLYCOSIDE DERIVATIVE AND USE THEREOF | FUJIFILM CORP (JP) | 2007-10-17 | — | — | EP | disclosed |
| CN-101048422-A | Benzonaphthaceneglycoside derivative and use thereof | FUJIFILM CORP (JP) | 2007-10-03 | — | — | CN | disclosed |
| WO-2006028229-A1 | BENZONAPHTHACENEGLYCOSIDE DERIVATIVE AND USE THEREOF | FUJIFILM CORPORATION (JP) | 2006-03-16 | — | — | WO | disclosed |
| EP-0925284-B1 | NEW POLYCYCLIC PHTHALAZIN DERIVATIVES AND THEIR USE | GRUENENTHAL GMBH (DE) | 2001-07-04 | — | — | EP | disclosed |
| US-6124290-A | TREATING BACTERIAL INFECTIONS | GRUENENTHAL GMBH (DE) | 2000-09-26 | — | — | US | disclosed |
| JP-2000028599-A | D-MANNOSE IDENTIFICATION AFFINITY CARRIER AND USING METHOD THEREFOR | EBARA CORP | 2000-01-28 | — | — | JP | disclosed |
| JP-2000001497-A | BENZONAPHTHACENEQUINONE DERIVATIVE | SEIKAGAKU KOGYO CO LTD | 2000-01-07 | — | — | JP | disclosed |
| EP-0940144-A1 | BIOACTIVE POLYMER PRODUCT | EBARA CORPORATION (JP) | 1999-09-08 | — | — | EP | disclosed |
| EP-0925284-A1 | NEW POLYCYCLIC PHTHALAZIN DERIVATIVES AND THEIR USE | Grünenthal GmbH (DE) | 1999-06-30 | — | — | EP | disclosed |
| WO-1998007706-A1 | NEW POLYCYCLIC PHTHALAZIN DERIVATIVES AND THEIR USE | Grünenthal GmbH (DE) | 1998-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190002942-A1 | ANTIBIOTIC FIIRV 104/18 COMPLEX AND THE ISOLATED INDIVIDUAL FACTORS THEREOF | MRPL38, F5, F8 | PTPRC 3115/4885MEN1 2523/4885KMT2A 3617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.